|
Meptazinol
|
DB13478 |
|
|
Histapyrrodine
|
DB13479 |
|
|
Menatetrenone
|
DB12148 |
[Menatetrenone has been used in trials studying the treatment of Diabetes, Osteoporosis, Prediabetic State, and Hepatocellular Carcinoma.] |
|
S-3304
|
DB12149 |
[S-3304 has been used in trials studying the treatment of Lung Cancer, Solid Tumors, Non Small Cell Lung Cancer, Stage IIIB Non Small Cell Lung Cancer, and Stage IIIA Non Small Cell Lung Cancer, among others.] |
|
Antimony pentasulfide
|
DB13473 |
|
|
Duligotuzumab
|
DB12142 |
[Duligotuzumab has been used in trials studying the treatment of Neoplasms, Colorectal Cancer, Head and Neck Cancer, and Epithelial Tumors, Malignant.] |
|
Rezatomidine
|
DB12143 |
[Rezatomidine has been used in trials studying the treatment of Fibromyalgia, Cystitis, Interstitial, Irritable Bowel Syndrome, and Diabetic Neuropathy, Painful.] |
|
Tipepidine
|
DB13474 |
|
|
Furazidin
|
DB13475 |
|
|
BMS-275183
|
DB12144 |
[BMS-275183 has been used in trials studying the treatment of Tumors and Non-small Cell Lung Cancer.] |
|
Diisopromine
|
DB13476 |
|
|
AZD-0328
|
DB12145 |
[AZD0328 has been used in trials studying the treatment and basic science of Schizophrenia and Alzheimer's Disease.] |
|
Cefodizime
|
DB13470 |
|
|
Dilmapimod
|
DB12140 |
[Dilmapimod has been used in trials studying the treatment and diagnostic of Nerve Trauma, Inflammation, Pain, Neuropathic, Arthritis, Rheumatoid, and Coronary Heart Disease, among others. Dilmapimod (SB-681323) is a p38 MAP-kinase inhibitor that has potential uses in inflammatory conditions such as RA (Rheumatoid Arthritis). Previous p38 MAP-kinase inhibitors have been hindered in development by liver toxicity. Methotrexate (common treatment for RA patients) also has potential liver toxicity.}] |
|
Nalfurafine
|
DB13471 |
|
|
Gilteritinib
|
DB12141 |
[Gilteritinib, also known as ASP2215, is a small molecule part of the FLT3 tyrosine kinase inhibitors that presented a greater selectivity and potency when compared with other agents from this group.[A40036] It is a pyrazinecarboxamide derivative that showed high selectivity to FLT3 preventing the c-Kit -driven myelosuppression observed in other therapies.[A40044] Gilteritinib was developed by Astellas Pharma and FDA approved on November 28, 2018. This drug was approved after being designed as an orphan drug with a fast track and priority review status.[L4830]] |
|
Cyclofenil
|
DB13472 |
|
|
Aspartame
|
DB00168 |
[Flavoring agent sweeter than sugar, metabolized as phenylalanine and aspartic acid.] |
|
Alphameprodine
|
DB01499 |
[Alphameprodine is an opioid analgesic classified by the United States Drug Enforcement Administration under Schedule I of illegal substances. The stereoisomer betameprodine is similarly classified, however alphameprodine is more widely used (both are referred to as Meprodine). Alphameprodine is a structural analogue of meperidine. It exerts physiological effects characteristic of opioids, such as analgesia, euphoria and sedation, as well as itching, nausea, and respiratory depression.] |
|
Isoleucine
|
DB00167 |
[An essential branched-chain aliphatic amino acid found in many proteins. It is an isomer of leucine. It is important in hemoglobin synthesis and regulation of blood sugar and energy levels.] |
